Abbott Laboratories (NYSE:ABT) will release earnings for its first quarter before the opening bell on Thursday, April 16.

Analysts expect the Abbott Park, Illinois-based company to report quarterly earnings of $1.15 per share. That’s up from $1.09 per share in the year-ago period. The consensus estimate for Abbott's quarterly revenue is $11 billion (it reported $10.36 billion last year), according to Benzinga Pro.

On March 23, Abbott completed the acquisition of Exact Sciences.

Shares of Abbott rose 0.4% to close at $100.69 on Monday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • Barclays analyst Matt Miksic maintained an Overweight rating and raised the price target from $142 to $144 on April 8, 2026. This analyst has an accuracy rate of 64%.
  • Evercore ISI Group analyst Vijay Kumar maintained an Outperform rating and cut the price target from $138 to $134 on April 6, 2026. This analyst has an accuracy rate of 55%.
  • BTIG analyst Marie Thibault maintained a Buy rating and cut the price target from $140 to $131 on March 31, 2026. This analyst has an accuracy rate of 58%.
  • Citigroup analyst Joanne Wuensch maintained a Buy rating and cut the price target from $140 to $136 on March 11, 2026. This analyst has an accuracy rate of 70%.
  • Bernstein analyst Lee Hambright maintained an Outperform rating and lowered the price target from $154 to $125 on Jan. 23, 2026. This analyst has an accuracy rate of 50%

Considering buying ABT stock? Here’s what analysts think:

Photo via Shutterstock